Posted on May 6, 2011 by Sitemaster
The final report of the result of the ASCENT-2 trial has been published on line in the Journal of Clinical Oncology. The data from this study have been widely reported in the past. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: ASCENT, calcitriol, castration-resistant, DN-101, docetaxel, mCRPC, metastatic | Leave a comment »
Posted on July 26, 2010 by Sitemaster
There are several interesting new publications worth commenting on this morning — all in the evolving research field as opposed to current clinical practice:
- Angiogenic effect of a specific statin on prostate cancer development
- Synergistic impact of calcitriol on cryotherapy
- Hybrid imaging techniques and prostate cancer
- GTI-2040 in treatment of CRPC … READ MORE …
Filed under: Drugs in development, Management, Risk, Treatment | Tagged: angiogenesis, calcitriol, cryotherapy, GTI-2040, hybrid, imaging, statin, synergy | Leave a comment »
Posted on September 12, 2009 by Sitemaster
Today’s news reports address studies on:
- Screening and its impact on prostate cancer-specific mortality
- Naproxen + calcitriol as first-line therapy for recurrent prostate cancer … READ MORE …
Filed under: Diagnosis, Drugs in development, Risk | Tagged: calcitriol, mortality, naproxen, screening | 5 Comments »
